Net income 2017
Net income 2018
P/E ratio 2017
P/E ratio 2018
EV / Sales2017
EV / Sales2018
Teligent, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's products...
Surperformance© ratings of IGI LABORIGI
Trading Rating :
Investor Rating :
Latest news on IGI LABORIGI
TELIGENT : reports 2Q loss
TELIGENT, INC. (NASDAQ : TLGT) Files An 8-K Results of Operations and Financial ..
TELIGENT, INC. : Results of Operations and Financial Condition, Financial Statem..
Teligent, Inc. Announces Second Quarter 2017 Results
TELIGENT INC : Investor Network: Teligent, Inc. to Host Earnings Call
Teligent, Inc. to Hold Conference Call for Second Quarter 2017 Results
TELIGENT : Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
TELIGENT, INC. : Announces FDA Approval Of Erythromycin Topical Gel USP, 2%
TELIGENT : Commerce Bank Has $145,000 Stake in Teligent Inc
TELIGENT, INC. (NASDAQ : TLGT) Files An 8-K Submission of Matters to a Vote of S..
Sector news : Pharmaceuticals - NEC
Number of Analysts
Average target price
Spread / Average Target